Yan Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yan Yan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Biao Tan
Wangjing Hospital, China Academy of Chinese Medical Sciences Beijing China
1 shared publication - Fanyu Fu
Guizhou University of Traditional Chinese Medicine Guiyang China
1 shared publication - Haijun He
Department of Orthopedic, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, China
1 shared publication Jiawen Zhang
Traumatic Joint Surgery Department, Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China
1 shared publication- Jigao Sun
Orthopedics Department, Dongfang Hospital Beijing University of Chinese Medicine, Beijing, China
1 shared publication - Qianglong Chen
Guizhou University of Traditional Chinese Medicine Guiyang China
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 15 (9) , 1159-1175
Diagnostic biomarkers for non-traumatic osteonecrosis of the femoral head
Aims: Many studies have focused on identifying specific biomarkers for the early diagnosis of non-traumatic osteonecrosis of the femoral head (NONFH). This systematic review aims to summarize biomarkers associated with the diagnosis and progression prediction of NONFH, thereby providing a molecular level foundation for clinical diagnosis and targeted treatment. Methods: Following the PRISMA guidelines for systematic reviews, we comprehensively searched original English-language articles published between January 2015 and December 2025 in the Web of Science and PubMed databases. Studies were selected based on the PICOS framework. Extracted data included study design, methodologies, sample sources, identified biomarkers, predictive performance, and the potential pathological pathways involved. Results: Overall, 15 studies were included, reporting a total of 52 biomarkers, all derived from blood samples. Biomarkers from eight studies were used to reflect NONFH progression, while those from seven studies were using for diagnostic prediction purposes. All biomarkers demonstrated favourable predictive performance, with six studies providing external validation. The predictive model comprising ICAM1, NR3C1, IKBKB, and CD4 showed promising performance, with area under the receiver operating characteristic curve (AUC) values each reaching 1.00. Based on their core functions, the biomarkers were categorized into seven functional groups: immune-inflammatory activation and response, signal transduction and regulation, molecular metabolism and energy homeostasis, vascular function and coagulation, oxidative stress, pyroptosis and autophagy, and RNA regulatory. Conclusion: Biomarkers for NONFH exhibit considerable potential for early diagnosis and disease progression prediction in the Chinese population. The pathogenesis of NONFH involves a multifaceted pathological process in which various components interact and synergistically exacerbate the condition. This indicates that future therapeutic strategies should adopt a multitarget, multipathway synergistic intervention approach. Cite this article: Bone Joint Res 2026;15(9):1159–1175.
- 21 September 2026
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 15 (9) , 1159-1175
Open AccessDiagnostic biomarkers for non-traumatic osteonecrosis of the femoral head
Aims: Many studies have focused on identifying specific biomarkers for the early diagnosis of non-traumatic osteonecrosis of the femoral head (NONFH). This systematic review aims to summarize biomarkers associated with the diagnosis and progression prediction of NONFH, thereby providing a molecular level foundation for clinical diagnosis and targeted treatment. Methods: Following the PRISMA guidelines for systematic reviews, we comprehensively searched original English-language articles published between January 2015 and December 2025 in the Web of Science and PubMed databases. Studies were selected based on the PICOS framework. Extracted data included study design, methodologies, sample sources, identified biomarkers, predictive performance, and the potential pathological pathways involved. Results: Overall, 15 studies were included, reporting a total of 52 biomarkers, all derived from blood samples. Biomarkers from eight studies were used to reflect NONFH progression, while those from seven studies were using for diagnostic prediction purposes. All biomarkers demonstrated favourable predictive performance, with six studies providing external validation. The predictive model comprising ICAM1, NR3C1, IKBKB, and CD4 showed promising performance, with area under the receiver operating characteristic curve (AUC) values each reaching 1.00. Based on their core functions, the biomarkers were categorized into seven functional groups: immune-inflammatory activation and response, signal transduction and regulation, molecular metabolism and energy homeostasis, vascular function and coagulation, oxidative stress, pyroptosis and autophagy, and RNA regulatory. Conclusion: Biomarkers for NONFH exhibit considerable potential for early diagnosis and disease progression prediction in the Chinese population. The pathogenesis of NONFH involves a multifaceted pathological process in which various components interact and synergistically exacerbate the condition. This indicates that future therapeutic strategies should adopt a multitarget, multipathway synergistic intervention approach. Cite this article: Bone Joint Res 2026;15(9):1159–1175.
- Open Access
- 14 June 2021
- Published by Wiley in Orthopaedic Surgery
- Vol. 13 (5) , 1474-1487
Exercise vs Conventional Treatment for Treatment of Primary Osteoporosis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Objective: Physical exercise has obvious effects on bone loss, pain relief, and improvement of bone metabolism indexes in patients with osteoporosis, but currently lacks sufficient evidence. The aim of this systematic review and meta‐analysis was to synthesize and present the best available evidence on the effectiveness and safety of exercises in the treatment of primary osteoporosis.Methods: Publications pertaining to the effectiveness of exercise on bone mineral density (BMD), visual analog scores (VAS), and biochemical markers of bone metabolism in primary osteoporosis (POP) from PubMed, Cochrane Library, Embase, VIP, CNKI, and Wanfang Database were retrieved from their inception to April 2020.Results: A total of 20 studies with 1824 participants were included. The results of the meta‐analysis revealed that exercise therapy for lumbar spine and femoral neck BMD is statistically different from conventional therapy (lumbar spine BMD: SMD = 0.78, 95%CI: 0.46, 1.10, P < 0.00001, I2 = 85%; femoral neck BMD (SMD = 0.80, 95%CI: 0.34, 1.27, P = 0.0007, I2 = 88%), exercise therapy can significantly increase the lumbar spine BMD of patients with OP, especially in lumbar spine2‐4 BMD (SMD = 0.47; 95%CI: 0.20, 0.75; P = 0.0008; I2 = 69%). Compared with conventional treatment, kinesitherapy also has significant differences in alleviating the pain of POP patients (SMD = −1.39, 95%CI: −2.47,−0.31, P = 0.01, I2 = 97%). Compared with conventional therapy, kinesitherapy has no significant difference in improving biochemical markers of bone metabolism such as bone glaprotein (BGP) (SMD = 2.59, 95%CI:0.90, 4.28, P = 0.003, I2 = 98%), N‐terminal pro peptide of type I procollagen (PINP) (SMD = 0.77, 95%CI: −0.44 to 1.98, P = 0.21, I2 = 95%), serum phosphorus (SMD = 0.04, 95%CI: −0.13, 0.22, P = 0.61, I2 = 30%), alkaline phosphatase (ALP) (SMD = −0.08, 95%CI: −0.44, 0.27, P = 0.64, I2 = 76%), and serum calcium (SMD = 0.12, 95%CI: −0.18, 0.43, P = 0.42, I2 = 63%) in POP patients.Conclusions: Kinesitherapy significantly improved lumbar spine and femoral neck BMD, and relieve the pain of patients in the current low‐quality evidence. Additional high‐quality evidence is required to confirm the effect of exercise therapy on the biochemical markers of bone metabolism in POP patients.
- 14 June 2021
- Published by Wiley in Orthopaedic Surgery
- Vol. 13 (5) , 1474-1487
Open AccessExercise vs Conventional Treatment for Treatment of Primary Osteoporosis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Objective: Physical exercise has obvious effects on bone loss, pain relief, and improvement of bone metabolism indexes in patients with osteoporosis, but currently lacks sufficient evidence. The aim of this systematic review and meta‐analysis was to synthesize and present the best available evidence on the effectiveness and safety of exercises in the treatment of primary osteoporosis.Methods: Publications pertaining to the effectiveness of exercise on bone mineral density (BMD), visual analog scores (VAS), and biochemical markers of bone metabolism in primary osteoporosis (POP) from PubMed, Cochrane Library, Embase, VIP, CNKI, and Wanfang Database were retrieved from their inception to April 2020.Results: A total of 20 studies with 1824 participants were included. The results of the meta‐analysis revealed that exercise therapy for lumbar spine and femoral neck BMD is statistically different from conventional therapy (lumbar spine BMD: SMD = 0.78, 95%CI: 0.46, 1.10, P < 0.00001, I2 = 85%; femoral neck BMD (SMD = 0.80, 95%CI: 0.34, 1.27, P = 0.0007, I2 = 88%), exercise therapy can significantly increase the lumbar spine BMD of patients with OP, especially in lumbar spine2‐4 BMD (SMD = 0.47; 95%CI: 0.20, 0.75; P = 0.0008; I2 = 69%). Compared with conventional treatment, kinesitherapy also has significant differences in alleviating the pain of POP patients (SMD = −1.39, 95%CI: −2.47,−0.31, P = 0.01, I2 = 97%). Compared with conventional therapy, kinesitherapy has no significant difference in improving biochemical markers of bone metabolism such as bone glaprotein (BGP) (SMD = 2.59, 95%CI:0.90, 4.28, P = 0.003, I2 = 98%), N‐terminal pro peptide of type I procollagen (PINP) (SMD = 0.77, 95%CI: −0.44 to 1.98, P = 0.21, I2 = 95%), serum phosphorus (SMD = 0.04, 95%CI: −0.13, 0.22, P = 0.61, I2 = 30%), alkaline phosphatase (ALP) (SMD = −0.08, 95%CI: −0.44, 0.27, P = 0.64, I2 = 76%), and serum calcium (SMD = 0.12, 95%CI: −0.18, 0.43, P = 0.42, I2 = 63%) in POP patients.Conclusions: Kinesitherapy significantly improved lumbar spine and femoral neck BMD, and relieve the pain of patients in the current low‐quality evidence. Additional high‐quality evidence is required to confirm the effect of exercise therapy on the biochemical markers of bone metabolism in POP patients.